Researchers examined whether getting a prescription for Paxlovid, an antiviral medication for COVID-19, was linked to a lower chance of being hospitalized. They looked at data from eligible adults in the United States who had COVID-19. The study found that people who were prescribed Paxlovid were 51% less likely to be hospitalized for COVID-19 compared to those who were not. This is a relative measure, meaning it shows a comparison between groups, but the study did not report the actual number of people hospitalized in each group.
It is important to understand this was an observational study. This type of research can find associations or links, but it cannot prove that taking Paxlovid directly caused the lower hospitalization rate. Other factors, like differences in the health of people who did or did not get the prescription, could explain the result. The study also did not report on side effects or safety concerns related to Paxlovid.
Because this is an observational finding, it should be viewed as an early signal. More rigorous research, like randomized controlled trials, is needed to confirm if Paxlovid is effective at preventing hospitalizations. Readers should know that this study supports the potential benefit of Paxlovid but does not provide definitive proof. Decisions about treatment should always be made in consultation with a healthcare provider based on individual circumstances.
